chemical compound inhibitor tryptophan catabolic enzyme indoleamine ido indo ec chiral compound exist lenantiomers lisomer inhibits ido weakly also serves enzyme substrate disomer inhibit ido inhibit idorelated enzyme restore mtor signaling cells starved tryptophan due ido also known indoximod currently clinical trials cancer treatment advanced us patent covering salt prodrug formulations indoximod issued newlink genetics august providing exclusivity least antineoplastic immunomodulatory drug article stub help wikipedia expanding article heterocyclic compound stub help wikipedia expanding